418 related articles for article (PubMed ID: 17475367)
1. Serotonin mediates rapid changes of striatal glucose and lactate metabolism after systemic 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") administration in awake rats.
Gramsbergen JB; Cumming P
Neurochem Int; 2007 Jul; 51(1):8-15. PubMed ID: 17475367
[TBL] [Abstract][Full Text] [Related]
2. Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines, MDMA ("Ecstasy") and MDA ("Love").
McNamara R; Kerans A; O'Neill B; Harkin A
Neuropharmacology; 2006 Jan; 50(1):69-80. PubMed ID: 16188283
[TBL] [Abstract][Full Text] [Related]
3. The effects of co-administration of 3,4-methylenedioxymethamphetamine ("ecstasy") or para-methoxyamphetamine and moclobemide at elevated ambient temperatures on striatal 5-HT, body temperature and behavior in rats.
Stanley N; Salem A; Irvine RJ
Neuroscience; 2007 Apr; 146(1):321-9. PubMed ID: 17306465
[TBL] [Abstract][Full Text] [Related]
4. Effects of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy') and para-methoxyamphetamine on striatal 5-HT when co-administered with moclobemide.
Freezer A; Salem A; Irvine RJ
Brain Res; 2005 Apr; 1041(1):48-55. PubMed ID: 15804499
[TBL] [Abstract][Full Text] [Related]
5. Hypothyroidism alters striatal dopamine release mediated by 3,4-methylenedioxymethamphetamine (MDMA, ecstasy).
Peterson AL; Gilman TL; Banks ML; Sprague JE
Synapse; 2006 Apr; 59(5):317-9. PubMed ID: 16421905
[TBL] [Abstract][Full Text] [Related]
6. On-line monitoring of striatum glucose and lactate in the endothelin-1 rat model of transient focal cerebral ischemia using microdialysis and flow-injection analysis with biosensors.
Gramsbergen JB; Skjøth-Rasmussen J; Rasmussen C; Lambertsen KL
J Neurosci Methods; 2004 Dec; 140(1-2):93-101. PubMed ID: 15589339
[TBL] [Abstract][Full Text] [Related]
7. Serotonin-GABA interactions modulate MDMA-induced mesolimbic dopamine release.
Bankson MG; Yamamoto BK
J Neurochem; 2004 Nov; 91(4):852-9. PubMed ID: 15525339
[TBL] [Abstract][Full Text] [Related]
8. Effect of repeated ('binge') dosing of MDMA to rats housed at normal and high temperature on neurotoxic damage to cerebral 5-HT and dopamine neurones.
Sanchez V; O'shea E; Saadat KS; Elliott JM; Colado MI; Green AR
J Psychopharmacol; 2004 Sep; 18(3):412-6. PubMed ID: 15358986
[TBL] [Abstract][Full Text] [Related]
9. The relationship between hyperthermia and glycogenolysis in 3,4-methylenedioxymethamphetamine-induced serotonin depletion in rats.
Darvesh AS; Gudelsky GA
Neurotoxicol Teratol; 2004; 26(4):571-7. PubMed ID: 15203179
[TBL] [Abstract][Full Text] [Related]
10. Risperidone attenuates and reverses hyperthermia induced by 3,4-methylenedioxymethamphetamine (MDMA) in rats.
Shioda K; Nisijima K; Yoshino T; Kuboshima K; Iwamura T; Yui K; Kato S
Neurotoxicology; 2008 Nov; 29(6):1030-6. PubMed ID: 18722468
[TBL] [Abstract][Full Text] [Related]
11. Modulation of methylenedioxymethamphetamine-induced striatal dopamine release by the interaction between serotonin and gamma-aminobutyric acid in the substantia nigra.
Yamamoto BK; Nash JF; Gudelsky GA
J Pharmacol Exp Ther; 1995 Jun; 273(3):1063-70. PubMed ID: 7791076
[TBL] [Abstract][Full Text] [Related]
12. Potentiation of 3,4-methylenedioxymethamphetamine-induced 5-HT release in the rat substantia nigra by clorgyline, a monoamine oxidase A inhibitor.
Hewton R; Salem A; Irvine RJ
Clin Exp Pharmacol Physiol; 2007 Oct; 34(10):1051-7. PubMed ID: 17714093
[TBL] [Abstract][Full Text] [Related]
13. Elevation of ambient room temperature has differential effects on MDMA-induced 5-HT and dopamine release in striatum and nucleus accumbens of rats.
O'Shea E; Escobedo I; Orio L; Sanchez V; Navarro M; Green AR; Colado MI
Neuropsychopharmacology; 2005 Jul; 30(7):1312-23. PubMed ID: 15688085
[TBL] [Abstract][Full Text] [Related]
14. Elevation of serum prolactin and corticosterone concentrations in the rat after the administration of 3,4-methylenedioxymethamphetamine.
Nash JF; Meltzer HY; Gudelsky GA
J Pharmacol Exp Ther; 1988 Jun; 245(3):873-9. PubMed ID: 2898523
[TBL] [Abstract][Full Text] [Related]
15. Evidence for the involvement of nitric oxide in 3,4-methylenedioxymethamphetamine-induced serotonin depletion in the rat brain.
Darvesh AS; Yamamoto BK; Gudelsky GA
J Pharmacol Exp Ther; 2005 Feb; 312(2):694-701. PubMed ID: 15456837
[TBL] [Abstract][Full Text] [Related]
16. Pre-treatment with 3,4-methylenedioxymethamphetamine (MDMA) causes long-lasting changes in 5-HT2A receptor-mediated glucose utilization in the rat brain.
Bull EJ; Porkess V; Rigby M; Hutson PH; Fone KC
J Psychopharmacol; 2006 Mar; 20(2):272-80. PubMed ID: 16510485
[TBL] [Abstract][Full Text] [Related]
17. Evidence for a role of energy dysregulation in the MDMA-induced depletion of brain 5-HT.
Darvesh AS; Gudelsky GA
Brain Res; 2005 Sep; 1056(2):168-75. PubMed ID: 16098955
[TBL] [Abstract][Full Text] [Related]
18. Acceleration of serotonin transporter transport-associated current by 3,4-methylenedioxymethamphetamine (MDMA) under acidic conditions.
Yamauchi Y; Izumi T; Unemura K; Uenishi Y; Nakagawa T; Kaneko S
Neurosci Lett; 2007 Nov; 428(2-3):72-6. PubMed ID: 17949903
[TBL] [Abstract][Full Text] [Related]
19. Association of caffeine to MDMA does not increase antinociception but potentiates adverse effects of this recreational drug.
Camarasa J; Pubill D; Escubedo E
Brain Res; 2006 Sep; 1111(1):72-82. PubMed ID: 16889759
[TBL] [Abstract][Full Text] [Related]
20. 3,4-Methylenedioxymethamphetamine produces glycogenolysis and increases the extracellular concentration of glucose in the rat brain.
Darvesh AS; Shankaran M; Gudelsky GA
J Pharmacol Exp Ther; 2002 Apr; 301(1):138-44. PubMed ID: 11907167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]